Skip to main content
77°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
Next >
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers
ALS
NEWS
WENA
Tags
Pre/Market Outlook
News
General
From
Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
July 03, 2024
Tickers
LLY
NEWS
Tags
Biotech
Alzheimer's disease
News
From
Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Oil and Gas
NVIDIA Corp
World Markets
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
World Markets
Medication
Technology
From
CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
June 21, 2024
Tags
Eric A/ Adams
InMed Pharmaceuticals
Expert Ideas
From
Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
Tags
Personal finance
Health insurance
Long/Term Care
From
CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
Benzinga
pharmaceuticals
Market News
From
Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
Tags
Alzheimer's disease
News
China Pharmaceutical University study
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
Health Care
alzheimer's
ESAIY
From
Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
Tags
Dementia
Make It
Health
From
CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
August 24, 2023
Tickers
TECH
Tags
machine learning
Nature's Scientific Reports
Entrepreneurship
From
Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
Tags
Health
Microsoft Corp
Make It / Power Players
From
CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
Market News
Cannabis
TOKE
From
Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
Tags
Medicare
Social Security
Retirement planning
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Medicare health plans
Science
Business News
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
alzheimer's treatment
General
Top Stories
From
Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Eisai Co Ltd
Science
Business News
From
CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
Tags
Parkinson's Disease
Eli Lilly (LLY)
Biogen Idec (BIIB)
From
Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
June 21, 2023
Tags
Series/A
sleep disorders
FloraWorks
From
Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
US: News
US Economy
Social issues
From
CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
Breaking News: Business
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
U/S/ Economy
Politics
Policy
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Politics
US Top News and Analysis
U/S/ Economy
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Business
Health care industry
Breaking News: Business
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Eisai Co Ltd
Business News
Science
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
lung cancer
Alzheimer's Disease
Merck (MRK)
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Anavex Life Sciences (AVXL)
Eisai (ESALY)
metformin
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
Lexeo Therapeutics
Doc Gumshoe
Merck (MRK)
From
Stock Gumshoe
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.